Cosmos Health Inc. (COSM): EBITDA
-$15.33M
Year ended 2025-12-31
-$16.94M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$15.33M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$14.30M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$21.22M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$7.29M | n/m | 2024-08-05, From 2022-01-01 |
| 2021-12-31 | -$4.08M | n/m | 2023-04-12, From 2021-01-01 |
| 2020-12-31 | $3.11M | n/m | 2022-12-16, From 2020-01-01 |
| 2019-12-31 | $138.8K | n/m | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | -$1.18M | n/a | 2020-04-14, From 2018-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | 2025-12-31 | -$15.33M | n/m |
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | -$90.54M | n/m |
| Stemtech Corp (STEK) | 2025-12-31 | -$2.54M | n/m |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $118.02M | n/m |
| Herbalife Ltd. (HLF) | 2025-12-31 | $602.20M | +18.7% |
| Cardinal Health Inc (CAH) | 2026-06-30 | $3.57B | +16.4% |
| Cencora, Inc. (COR) | 2025-09-30 | $3.68B | +12.6% |
| McKesson Corp (MCK) | 2026-03-31 | $6.94B | +37.2% |
Compare COSM, MEDS, STEK, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗